BDX vs TMDX · P/E 34, rev $21.84B vs P/E 17, rev $363.9M
Becton Dickinson and Company (BDX) versus TransMedics Group Inc (TMDX) — a side-by-side from cached financials, not a winner call.
Becton Dickinson and Company (BDX) is a medical instruments & supplies company listed on US.
TransMedics Group Inc (TMDX) is a medical devices company listed on NASDAQ.
Latest reported BDX revenue for 2025-09-30 was $21.84B. Net income was $1.68B. BDX currently screens at market cap $50.30B and trailing P/E 33.9.
Latest reported TMDX revenue for 2026-06-30 was $363.9M. Net income was $22.0M. TMDX currently screens at market cap $2.53B and trailing P/E 16.8.
BDX currently screens at market cap $50.30B and trailing P/E 33.9. TMDX currently screens at market cap $2.53B and trailing P/E 16.8.
Not investment advice. Open the BDX and TMDX stock pages for the full models.
Not investment advice.